IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q3 2025 Holdings

Filed 2025-11-03 | 2 holdings | $29.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Kyverna Therapeutics Inc(KYTX)COM501976104$27.1M4,523,92492.4%
Allogene Therapeutics Inc(ALLO)COM019770106$2.2M1,798,1637.6%